Chooi Lee

A phase Ib trial of continuous once-daily oral afatinib plus sirolimus in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and/or disease progression following prior erlotinib or gefitinib

Teresa Morán, Ramón Palmero, Mariano Provencio et al. · Lung Cancer · 2017 · 24 citations

Medicine, Oncology, Pharmacology +13

A phase I study of BI 811283, an Aurora B kinase inhibitor, in patients with advanced solid tumors

K. Mross, Heike Richly, Annette Frost et al. · Cancer Chemotherapy and Pharmacology · 2016 · 19 citations · Full text

Medicine, Oncology, Pharmacology +15

A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors

Christian Dittrich, Michael Fridrik, Robert A. Koenigsberg et al. · Investigational New Drugs · 2014 · 18 citations · Full text

Pharmacy, Oncology, Pharmacology +17

A phase I study of two dosing schedules of oral BI 847325 in patients with advanced solid tumors

Patrick Schöffski, Philippe Aftimos, Herlinde Dumez et al. · Cancer Chemotherapy and Pharmacology · 2015 · 18 citations

Pharmacy, Oncology, Pharmacokinetics +11

Phase I first-in-man trial of a novel bromodomain and extra-terminal domain (BET) inhibitor (BI 894999) in patients (Pts) with advanced solid tumors.

Philippe Aftimos, Oliver Bechter, Ahmad Awada et al. · Journal of Clinical Oncology · 2017 · 18 citations

Medicine, Oncology, Pharmacology +13